0000950123-11-074327.txt : 20110808 0000950123-11-074327.hdr.sgml : 20110808 20110808143424 ACCESSION NUMBER: 0000950123-11-074327 CONFORMED SUBMISSION TYPE: N-CSRS/A PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20100930 FILED AS OF DATE: 20110808 DATE AS OF CHANGE: 20110808 EFFECTIVENESS DATE: 20110808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: RYDEX SERIES FUNDS CENTRAL INDEX KEY: 0000899148 IRS NUMBER: 000000000 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: N-CSRS/A SEC ACT: 1940 Act SEC FILE NUMBER: 811-07584 FILM NUMBER: 111016708 BUSINESS ADDRESS: STREET 1: 805 KING FARM BLVD STREET 2: SUITE 600 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 301-296-5100 MAIL ADDRESS: STREET 1: 805 KING FARM BLVD STREET 2: SUITE 600 CITY: ROCKVILLE STATE: MD ZIP: 20850 FORMER COMPANY: FORMER CONFORMED NAME: RYDEX SERIES TRUST DATE OF NAME CHANGE: 19930714 0000899148 S000003657 U.S. Government Money Market Fund C000010172 Investor RYMXX C000010173 Advisor RYDXX C000010174 A RYAXX C000010175 C RYCXX C000076811 Investor2 Class Shares 0000899148 S000003683 Banking Fund C000010303 Investor RYKIX C000010304 Advisor RYKAX C000010305 A RYBKX C000010306 C RYKCX 0000899148 S000003684 Government Long Bond 1.2x Strategy Fund C000010307 Investor RYGBX C000010308 Advisor RYADX C000010309 A RYABX C000010310 C RYCGX 0000899148 S000003685 Mid-Cap 1.5x Strategy Fund C000010311 H RYMDX C000010312 A RYAHX C000010313 C RYDCX 0000899148 S000003686 U.S. Long Short Momentum Fund C000010314 H RYSRX C000010315 A RYAMX C000010316 C RYISX 0000899148 S000003687 Global 130/30 Strategy Fund C000010317 H RYQMX C000010318 A RYASX C000010319 C RYQCX 0000899148 S000003688 S&P 500 Pure Value Fund C000010320 H RYZAX C000010321 A RYLVX C000010322 C RYVVX 0000899148 S000003689 S&P 500 Pure Growth Fund C000010323 H RYAWX C000010324 A RYLGX C000010325 C RYGRX 0000899148 S000003690 Inverse Government Long Bond Strategy Fund C000010326 Investor RYJUX C000010327 Advisor RYJAX C000010328 A RYAQX C000010329 C RYJCX 0000899148 S000003691 Nova Fund C000010330 Investor RYNVX C000010331 Advisor RYNAX C000010332 A RYANX C000010333 C RYNCX 0000899148 S000003692 Inverse S&P 500 Strategy Fund C000010334 Investor RYURX C000010335 Advisor RYUAX C000010336 A RYARX C000010337 C RYUCX 0000899148 S000003693 NASDAQ-100 Fund C000010338 Investor RYOCX C000010339 Advisor RYAOX C000010340 A RYATX C000010341 C RYCOX 0000899148 S000003694 Inverse NASDAQ-100 Strategy Fund C000010342 Investor RYAIX C000010343 Advisor RYAAX C000010344 A RYAPX C000010345 C RYACX 0000899148 S000003695 Europe 1.25x Strategy Fund C000010346 H RYEUX C000010347 A RYAEX C000010348 C RYCEX 0000899148 S000003697 Russell 2000 1.5x Strategy Fund C000010352 H RYMKX C000010353 A RYAKX C000010354 C RYCMX 0000899148 S000003760 S&P SmallCap 600 Pure Value Fund C000010429 H RYAZX C000010430 A RYSVX C000010431 C RYYCX 0000899148 S000003761 Weakening Dollar 2x Strategy Fund C000010432 H RYWBX C000010433 A RYWDX C000010434 C RYWJX 0000899148 S000003768 S&P SmallCap 600 Pure Growth Fund C000010445 H RYWAX C000010446 A RYSGX C000010447 C RYWCX 0000899148 S000003769 S&P MidCap 400 Pure Value Fund C000010448 H RYAVX C000010449 A RYMVX C000010450 C RYMMX 0000899148 S000003770 S&P MidCap 400 Pure Growth Fund C000010451 H RYBHX C000010452 A RYMGX C000010453 C RYCKX 0000899148 S000003771 Inverse Mid-Cap Strategy Fund C000010454 H RYMHX C000010455 A RYAGX C000010456 C RYCLX 0000899148 S000003772 Inverse Russell 2000 Strategy Fund C000010457 H RYSHX C000010458 A RYAFX C000010459 C RYCQX 0000899148 S000003773 Real Estate Fund C000010460 H RYHRX C000010461 A RYREX C000010462 C RYCRX 0000899148 S000003775 Strengthening Dollar 2x Strategy Fund C000010466 H RYSBX C000010467 A RYSDX C000010468 C RYSJX 0000899148 S000003798 Precious Metals Fund C000010578 Investor RYPMX C000010579 Advisor RYMPX C000010580 A RYMNX C000010581 C RYZCX 0000899148 S000003799 Telecommunications Fund C000010582 Investor RYMIX C000010583 Advisor RYMAX C000010584 A RYTLX C000010585 C RYCSX 0000899148 S000003800 Transportation Fund C000010586 Investor RYPIX C000010587 Advisor RYPAX C000010588 A RYTSX C000010589 C RYCNX 0000899148 S000003801 Energy Services Fund C000010590 Investor RYVIX C000010591 Advisor RYVAX C000010592 A RYESX C000010593 C RYVCX 0000899148 S000003802 Biotechnology Fund C000010594 Investor RYOIX C000010595 Advisor RYOAX C000010596 A RYBOX C000010597 C RYCFX 0000899148 S000003803 Electronics Fund C000010598 Investor RYSIX C000010599 Advisor RYSAX C000010600 A RYELX C000010601 C RYSCX 0000899148 S000003804 Internet Fund C000010602 Investor RYIIX C000010603 Advisor RYIAX C000010604 A RYINX C000010605 C RYICX 0000899148 S000003805 Utilities Fund C000010606 Investor RYUIX C000010607 Advisor RYAUX C000010608 A RYUTX C000010609 C RYCUX 0000899148 S000003806 Energy Fund C000010610 Investor RYEIX C000010611 Advisor RYEAX C000010612 A RYENX C000010613 C RYECX 0000899148 S000003807 Financial Services Fund C000010614 Investor RYFIX C000010615 Advisor RYFAX C000010616 A RYFNX C000010617 C RYFCX 0000899148 S000003808 Health Care Fund C000010618 Investor RYHIX C000010619 Advisor RYHAX C000010620 A RYHEX C000010621 C RYHCX 0000899148 S000003809 Technology Fund C000010622 Investor RYTIX C000010623 Advisor RYTAX C000010624 A RYTHX C000010625 C RYCHX 0000899148 S000003810 Basic Materials Fund C000010626 Investor RYBIX C000010627 Advisor RYBAX C000010628 A RYBMX C000010629 C RYBCX 0000899148 S000003811 Consumer Products Fund C000010630 Investor RYCIX C000010631 Advisor RYCAX C000010632 A RYPDX C000010633 C RYCPX 0000899148 S000003812 Leisure Fund C000010634 Investor RYLIX C000010635 Advisor RYLAX C000010636 A RYLSX C000010637 C RYLCX 0000899148 S000003813 Retailing Fund C000010638 Investor RYRIX C000010639 Advisor RYRAX C000010640 A RYRTX C000010641 C RYRCX 0000899148 S000012221 S&P 500 Fund C000033368 A-Class Shares RYSOX C000033369 C-Class Shares RYSYX C000033370 H-Class Shares RYSPX 0000899148 S000012222 Russell 2000 Fund C000033371 A-Class Shares RYRRX C000033372 C-Class Shares RYROX C000033373 H-Class Shares RYRHX 0000899148 S000012545 All-Asset Conservative Strategy Fund C000034110 A-Class Shares RYEOX C000034111 C-Class Shares RYEEX C000034112 H-Class Shares RYEPX 0000899148 S000012546 All-Asset Moderate Strategy Fund C000034113 A-Class Shares RYMOX C000034114 C-Class Shares RYMYX C000034115 H-Class Shares RYMLX 0000899148 S000012547 All-Asset Aggressive Strategy Fund C000034116 A-Class Shares RYGGX C000034117 C-Class Shares RYGEX C000034118 H-Class Shares RYGHX 0000899148 S000014095 Equity Market Neutral Fund C000038558 A-Class Shares C000038559 C-Class Shares C000038560 H-Class Shares C000088409 Institutional Class Shares 0000899148 S000015881 High Yield Strategy Fund C000043615 A-Class Shares RYHDX C000043616 C-Class Shares RYHHX C000043617 H-Class Shares RYHGX 0000899148 S000015882 Inverse High Yield Strategy Fund C000043618 A-Class Shares RYILX C000043619 C-Class Shares RYIYX C000043620 H-Class Shares RYIHX 0000899148 S000017776 International Long Short Select Fund C000049091 A-Class Shares RYFRX C000049092 C-Class Shares RYFWX C000049093 H-Class Shares RYFHX 0000899148 S000018293 Japan 2x Strategy Fund C000050428 A-Class RYJSX C000050429 C-Class RYJTX C000050430 H-Class RYJHX 0000899148 S000020995 Alternative Strategies Allocation Fund C000059639 H-Class RYFOX C000059640 A-Class RYFDX C000059641 C-Class RYFFX 0000899148 S000029171 Event Driven and Distressed Strategies Fund C000089668 A-Class Shares RYDOX C000089669 C-Class Shares RYDQX C000089670 H-Class Shares RYDSX C000089671 Institutional Class Shares RYDTX 0000899148 S000029172 Alternative Strategies Fund C000089672 A-Class Shares RYEMX C000089673 C-Class Shares RYERX C000089674 H-Class Shares RYETX C000089675 Institutional Class Shares RYEWX 0000899148 S000029173 Long Short Equity Strategy Fund C000089676 C-Class Shares RYJKX C000089677 H-Class Shares RYJLX C000089678 Institutional Class Shares RYJMX C000089679 A-Class Shares RYJJX 0000899148 S000029174 Long Short Interest Rate Strategy Fund C000089680 A-Class Shares RYBSX C000089681 C-Class Shares RYBTX C000089682 H-Class Shares RYBUX C000089683 Institutional Class Shares RYBVX N-CSRS/A 1 w83835nvcsrsza.htm FORM N-CSRS/A nvcsrsza
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM N-CSR/A
CERTIFIED SHAREHOLDER REPORT OF REGISTERED MANAGEMENT INVESTMENT COMPANIES
Investment Company Act file number 811-07584
Rydex Series Funds
(Exact name of registrant as specified in charter)
805 King Farm Boulevard, Suite 600
Rockville, Maryland 20850
(Address of principal executive offices) (Zip code)
Richard M. Goldman, President
Rydex Series Funds
805 King Farm Boulevard, Suite 600
Rockville, Maryland 20850
(Name and address of agent for service)

Registrant’s telephone number, including area code: 1-301-296-5100
 
Date of fiscal year end: March 31
 
Date of reporting period: September 30, 2010
*Explanatory Note
The Registrant is filing this amendment to its Form N-CSR for the period ended September 30, 2010, originally filed with the Securities and Exchange Commission on December 8, 2010 (Accession Number 0000950123-10-111634) to amend Item 1 “Reports to Stockholders.” The purpose of this amendment is to supplement the Semi-Annual Shareholder Reports for the Rydex Series Funds.
Items 1 (supplemented further herein), and 2 through 12(a)(1) to this Form N-CSR are incorporated by reference to the Form N-CSR filed on EDGAR on December 8, 2010 (Accession Number 0000950123-10-111634).
 
 

 


 

RYDEX SERIES FUNDS
Supplement dated July 22, 2011
to the Semi-Annual Report to Shareholders dated September 30, 2010 (“Semi-Annual Report”)
This Supplement provides new and additional information beyond that contained in the above-dated Semi-Annual Report for the Rydex Series Funds (the “Fund”) and should be read in conjunction with the Semi-Annual Report.
Board Considerations in Approving the Investment Advisory and Investment Sub-Advisory Agreements
At in-person meetings of the Trust’s Board of Trustees held May 19, 2010 with respect to the Event Driven and Distressed Strategies Fund, Alternative Strategies Fund, Long Short Equity Strategy Fund, and Long Short Treasury Fund, and August 25, 2010 with respect to Emerging Markets 2X Strategy Fund and Inverse Emerging Markets 2X Strategy Fund, called for the purpose of, among other things, voting on the approval of an amended investment advisory agreement applicable to those series of the Trust (collectively, the “Funds”), the Trust’s Board of Trustees, including the Independent Trustees, unanimously approved the amended investment advisory agreement between the Trust and Rydex Advisors, LLC (referred to herein as “Rydex”). At an in-person meeting of the Trust’s Board of Trustees held June 6, 2010, called for the purpose of, among other things, voting on the approval of a new investment sub-advisory agreement applicable to the Long Short Treasury Fund, the Trust’s Board of Trustees, including the Independent Trustees, unanimously approved the new investment sub-advisory agreement between Rydex and American Independence Financial Services, LLC (“AIFS”) with respect to the Long Short Treasury Fund. In reaching the conclusion to approve the investment advisory and investment sub-advisory agreements, the Trustees requested and obtained from Rydex such information as the Trustees deemed reasonably necessary to evaluate the proposed agreements. The Trustees carefully evaluated this information and were advised by legal counsel with respect to their deliberations.
In considering the approval of the investment advisory and investment sub-advisory agreements, the Independent Trustees evaluated a number of considerations, including, among others, (1) the nature, extent, and quality of the advisory services to be provided by Rydex and the investment sub-advisor; (2) the investment performance of the Funds; (3) the costs of services to be provided by Rydex; (4) a comparison of each Fund’s expense ratios and those of similarly situated funds; (5) the quality of the presentation made by AIFS; (6) the results of an onsite due diligence review of AIFS; and (7) other factors the Board deemed to be relevant. The Board also took into account other considerations that it believed, in light of the legal advice furnished to the Independent Trustees by their independent legal counsel and the Trustees’ own business judgment, to be relevant. Following its review, the Trust’s Board determined that the investment advisory agreement and investment sub-advisory agreement would enable Fund shareholders to obtain high quality services at a cost that is appropriate, reasonable and in the best interests of shareholders. Accordingly, the Trustees, including the Independent Trustees, unanimously

 


 

approved the investment advisory and investment sub-advisory agreement based upon the following considerations, among others:
    The nature, extent and quality of the advisory services to be provided. The Board of Trustees concluded that Rydex and the investment sub-advisor are capable of providing high quality services to the Funds, as indicated by the nature and quality of services provided by Rydex in the past and the experience of the investment sub-adviser in providing investment advisory services to mutual funds, Rydex’s management capabilities demonstrated with respect to the Funds and other mutual funds managed by Rydex, the professional qualifications and experience of Rydex and the investment sub-adviser, and Rydex’s investment and management oversight processes. The Trustees also determined that Rydex proposed to provide investment and related services that were of the same quality and quantity as services provided to the Funds in the past, and that these services are appropriate in scope and extent in light of the Funds’ operations, the competitive landscape of the investment company business and investor needs.
 
    The investment performance of the Advisors. The Trustees considered Rydex’s past performance and experience with index replication and considered the investment sub-adviser’s historical performance in approving the appointment of Rydex and the investment sub-adviser.
 
    The cost of advisory services provided and the level of profitability. On the basis of the Board’s review of the fees to be charged by Rydex for investment advisory and other services, and the estimated profitability of Rydex’s relationship with the Funds, the Board concluded that the level of investment advisory fees and Rydex’s profitability are appropriate in light of the management fees and overall expense ratios of comparable investment companies and the anticipated profitability of the relationship between each Fund and Rydex and its affiliates. The Trustees determined that the advisory fees, sub-investment advisory fee, and estimated overall expense ratio of each Fund are competitive with industry medians, particularly with respect to mutual funds of comparable size. With respect to the sub-investment advisory fee, the Board considered that the fee was negotiated in an arm’s length transaction.
 
    Whether the advisory fees reflect economies of scale. The Trustees concluded that the consideration of economies of scale was not appropriate at the present time since the funds were new and as yet had no assets.
On the basis of the information provided to it and its evaluation of that information, the Board, including the Independent Trustees, concluded that the terms of the investment advisory and investment sub-advisory agreement for the Funds were reasonable, and that approval of the investment advisory and investment sub-advisory agreement were in the best interests of the Funds.
     You may obtain a copy of the Fund’s Semi-Annual Report free of charge, upon request, by calling toll-free 1-800-820-0888, by visiting the Fund’s website at http://www.rydex-sgi.com/service/prospectuses_reports.shtml, or by writing to Rydex Distributors, LLC, 805 King Farm Boulevard, Suite 600, Rockville, Maryland 20850.

 


 

PLEASE RETAIN THIS SUPPLEMENT FOR YOUR FUTURE REFERENCE.

 


 

Item 12. Exhibits.
    (a)(2) Separate certifications by the President (principal executive officer) and Treasurer (principal financial officer) of the registrant as required by Rule 30a-2(a) under the Act (17 CFR 270.30a-2(a)) are attached.
 
(b)   A certification by the registrant’s President (principal executive officer) and Treasurer (principal financial officer) as required by Rule 30a-2(b) under the Act (17 CFR 270.30a-2(b)) is attached.

 


 

         
SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
         
(Registrant) Rydex Series Funds    
 
       
By:
  /s/ Richard Goldman
 
Richard Goldman, President
   
 
       
Date: August 5, 2011    
     Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.
         
By:
  /s/ Richard Goldman
 
Richard Goldman, President
   
 
       
Date: August 5, 2011    
 
       
By:
  /s/ Nikolaos Bonos
 
Nikolaos Bonos, Vice President and Treasurer
   
 
       
Date: August 5, 2011    

 

EX-99.CERT 2 w83835exv99wcert.htm EX-99.CERT exv99wcert
EX.-12(a)(2)(i)
CERTIFICATIONS
I, Richard Goldman, certify that:
1. I have reviewed this report on Form N-CSR of Rydex Series Funds;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
  (a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
  (b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
  (c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
 
  (d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 


 

5. The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
  (a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
 
  (b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 5, 2011
         
     
  /s/ Richard Goldman    
  Richard Goldman,   
  President   
 

 


 

EX.-12(a)(2)(ii)
CERTIFICATIONS
I, Nikolaos Bonos, certify that:
1. I have reviewed this report on Form N-CSR of Rydex Series Funds;
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations, changes in net assets, and cash flows (if the financial statements are required to include a statement of cash flows) of the registrant as of, and for, the periods presented in this report;
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
  (a)   Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
  (b)   Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
 
  (c)   Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report based on such evaluation; and
 
  (d)   Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the second fiscal quarter of the period covered by this report that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5. The registrant’s other certifying officer(s) and I have disclosed to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 


 

  (a)   All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize, and report financial information; and
 
  (b)   Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: August 5, 2011
         
     
  /s/ Nikolaos Bonos    
  Nikolaos Bonos,   
  Vice President & Treasurer   
 

 

EX-99.906CERT 3 w83835exv99w906cert.htm EX-99.906CERT exv99w906cert
EX. –12(b)(i)
CERTIFICATIONS
I, Richard Goldman, President of Rydex Series Funds (the “Trust”), certify that:
  1.   The Form N-CSR of the Trust (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
  2.   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust.
A signed original of this written statement required by Section 906 has been provided to the Trust and will be retained by the Trust and furnished to the Securities and Exchange Commission or its staff upon request.
Dated: August 5, 2011
         
     
  /s/ Richard Goldman    
  Richard Goldman,   
  President   

 


 

         
EX. –12(b)(ii)
CERTIFICATIONS
I, Nikolaos Bonos, Vice President and Treasurer of Rydex Series Funds (the “Trust”), certify that:
  1.   The Form N-CSR of the Trust (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
  2.   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Trust.
A signed original of this written statement required by Section 906 has been provided to the Trust and will be retained by the Trust and furnished to the Securities and Exchange Commission or its staff upon request.
Dated: August 5, 2011
         
     
  /s/ Nikolaos Bonos    
  Nikolaos Bonos,   
  Vice President and Treasurer